ScholarIQanswers from OpenAlex & ORCID
Anthony T.�C. Chan
ResearcherPublications, citations & collaboration network
Anthony T.�C. Chan is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Anthony T.�C. Chan have?
ScholarIQindexed works
Anthony T.�C. Chan has 723 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Anthony T.�C. Chan have?
ScholarIQcitation count
Anthony T.�C. Chan has 41,331 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Anthony T.�C. Chan?
ScholarIQh-index
Anthony T.�C. Chan has an h-index of 105 in OpenAlex.
What is the i10-index of Anthony T.�C. Chan?
ScholarIQi10-index
Anthony T.�C. Chan has an i10-index of 350 in OpenAlex.
What is the ORCID of Anthony T.�C. Chan?
ScholarIQorcid
The ORCID for Anthony T.�C. Chan is on the source record.
What is the OpenAlex record for Anthony T.�C. Chan?
ScholarIQopenalex
The OpenAlex for Anthony T.�C. Chan is on the source record.
What are the most-cited papers on Anthony T.�C. Chan?
ScholarIQmost cited works
Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis
Pierre Blanchard, Anne Lee, Sophie Marguet, Julie Leclercq, Wai Tong Ng, Jun Ma, Anthony T.�C. Chan, Pei‐Yu Huang, E Benhamou, Guopei Zhu, Daniel T. T. Chua, Yong Chen, Hai‐Qiang Mai, Dora L.�W. Kwong, Shie Lee Cheah, James Moon, Yuk Tung, Kwan‐Hwa Chi, George Fountzilas, Li Zhang, Edwin P. Hui, Tai‐Xiang Lu, Jean Bourhis, Jean‐Pierre Pignon
Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)
Brigette Ma, Wan‐Teck Lim, Boon Cher Goh, Edwin P. Hui, Kwok Wai Lo, Adam Pettinger, Nathan R. Foster, Jonathan W. Riess, Mark Agulnik, Alex Y. Chang, Akhil Chopra, Julie A. Kish, Christine H. Chung, Douglas R. Adkins, Kevin J. Cullen, Barbara J. Gitlitz, Dean Lim, Ka‐Fai To, K.C. Allen Chan, Yuk Ming Dennis Lo, Ann D. King, Charles Erlichman, Jun Yin, Brian A. Costello, Anthony T.�C. Chan
What Is the Best Treatment of Locally Advanced Nasopharyngeal Carcinoma? An Individual Patient Data Network Meta-Analysis
Laureen Ribassin-Majed, Sophie Marguet, Anne W.M. Lee, Wai Tong Ng, Jun Ma, Anthony T.�C. Chan, Pei‐Yu Huang, Guopei Zhu, Daniel T. T. Chua, Yong Chen, Hai-Qiang Mai, Dora L.�W. Kwong, Shie-Lee Cheah, James Moon, Yuk Tung, Kwan-Hwa Chi, George Fountzilas, Jean Bourhis, Jean‐Pierre Pignon, Pierre Blanchard, on behalf of the Meta-Analysis of Chemotherapy in Nasopharyngeal Collaborative Group
Multicenter, Phase II Study of Cetuximab in Combination With Carboplatin in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma
Anthony T.�C. Chan, Mow-Ming Hsu, Boon Cher Goh, Edwin P. Hui, Tsang‐Wu Liu, Michael Millward, Ruey‐Long Hong, Jacqueline Whang‐Peng, Brigette Ma, Ka‐Fai To, M. Mueser, Nadia Amellal, Xiao Lin, Alex Y. Chang
Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation
Jianming Ying, H Li, T J Seng, Cordelia Langford, Gopesh Srivastava, Sai Wah Tsao, Thomas Choudary Putti, Paul G. Murray, Anthony T.�C. Chan, Qian Tao